[1,3‐Bis(2‐ethoxy­phenyl)imidazolidin‐2‐yl­idene]bromo­(cyclo­octa‐1,5‐diene)­rhodium(I)

The title complex, [RhBr(C₈H₁₂)(C₁₉H₂₂N₂O₂)], has a distorted square‐planar geometry. There are two mol­ecules, A and B, in the asymmetric unit. The Rh—C bond distance between the N‐heterocyclic ligand and the metal atom is 2.039 (2) Å in mol­ecule A and 2.042 (2) Å in mol­ecule B. The angle between the carbene heterocycle and the coordination plane is 87.56 (12)° in mol­ecule A and 87.03 (11)° in mol­ecule B. It is shown that the average Rh—C(COD) (COD is cyclo­octa­diene) distance is linearly dependent on the Rh—C(imidazolidine) distance in this type of compound. This can be ascribed to the steric hindrance produced by the packing. The crystal structure contains intra­molecular C—H⋯O and inter­molecular C—H⋯Br inter­actions.     

4‐Chloro­aceto­phenone [1‐(4‐methoxyphenyl)­ethyl­idene]­hydra­zone

The crystal structure of the title mixed azine, C₁₇H₁₇ClN₂O, contains four independent mol­ecules, A–D, and mol­ecule B is disordered. All four mol­ecules have an N—N gauche conformation, with C—N—N—C torsion angles of 136.5 (4), 137.0 (4), ?134.7 (4) and ?134.7 (4)°, respectively. The phenyl rings are also somewhat twisted with respect to the plane defined by C_ipso and the imine bond. On average, the combined effect of these twists results in an angle of 64.7° between the best planes of the two phenyl rings. Arene–arene double T‐contacts are the dominant intermolecular inter­action. The methoxy‐substituted phenyl ring of one azine mol­ecule interacts to form a T‐contact with the methoxy‐substituted phenyl ring of an adjacent mol­ecule and, similarly, two chloro‐substituted phenyl rings of neighboring mol­ecules interact to form another T‐contact. The only exception is for mol­ecule B, for which the disorder leads to the formation of T‐­contacts between methoxy‐ and chloro‐substituted phenyl rings. The prevailing structural motif of T‐contact formation between like‐substituted arene rings results in a highly dipole‐parallel‐aligned crystal structure.     

[2,6‐Bis(1H‐benzimidazol‐2‐yl‐κN3)­pyridine‐κN](di­methyl­form­amide‐κO)­(thio­sulfato‐κ2O,S)­nickel(II) mono­hydrate

The structure of the title compound, [Ni(ths)(bbip)(dmf)]·­H₂O [ths is thio­sulfate, S₂O₃; bbip is 2,6‐bis(1H‐benz­imidazol‐2‐yl)­pyridine, C₂₁H₁₃N₅; and dmf is di­methyl­form­amide, C₃H₇NO], is monomeric, with the nickel ion octahe­drally surrounded by an N,N′,N′′‐tridentate bbip mol­ecule, an S,O‐bidentate ths mol­ecule and an O‐monodentate dmf mol­ecule. The H atoms of the hydration water mol­ecule and the amino groups of bbip are involved in hydrogen bonding and determine a spatial organization of broad layers parallel to (001), which are connected by weak interactions.     

3,5‐Di­amino‐6‐(2‐fluoro­phenyl)‐1,2,4‐triazine–di­methyl­form­amide (1/1)

The title compound, C₉H₈FN₅·C₃H₇NO, contains two independent complexes in the asymmetric unit, each consisting of one 3,5‐di­amino‐6‐(2‐fluoro­phenyl)‐1,2,4‐triazine mol­ecule and one di­methyl­form­amide solvent mol­ecule. One triazine mol­ecule is disordered over two conformations within the crystal, the occupancies being 62 (1) and 38 (1)%. The phenyl ring of this mol­ecule resolves into two conformations rotated by almost 180° about the bridging bond between the two rings, while the triazine rings approximately superimpose on each other. The triazine mol­ecules of the asymmetric unit differ in the dihedral angles between their respective phenyl and triazine ring planes, these being 57.6 (2)° for the fully occupied, and 76.9 (6) and 106.8 (8)° for the partially occupied mol­ecules. An extensive network of hydrogen bonds maintains the crystal structure.     

Bis(μ‐1,10‐phenanthrolin‐2‐olato‐κ3N,N′:O)­dicopper(I)(Cu—Cu) monohydrate

The crystal structure of the title compound, [Cu₂(C₁₂H₇­N₂O)₂]·H₂O, shows that this dinuclear complex has shorter Cu—N, Cu—O and Cu—Cu distances within the coordination sphere than similar reported complexes. The complex mol­ecule is located on a centre of symmetry and the water mol­ecule is on a twofold axis of the space group C2/c. The discrete complex mol­ecules are extended into a two‐dimensional supramolecular array viaπ–π stacking interactions, intermolecular Cu⋯Cu interactions and C—H⋯O hydrogen bonds.     

l‐Kynureninium sulfate dihydrate

In the structure of the title compound, 2‐(3‐ammonio‐3‐carboxy­propanoyl)‐1‐anilinium sulfate dihydrate, C₁₀H₁₄N₂O₃²⁺·SO₄^2?·2H₂O, the two amino groups are proton­ated. The mol­ecule has a trans planar zigzag carbon‐skeletal conformation elongated nearly in the benzene ring plane. The two amino and the carboxyl groups are located on the same side of the mol­ecule. The crystal structure is stabilized by intermolecular hydrogen bonds involving the water mol­ecules and the sulfate ion.     

Bis{1‐[N‐(2‐methoxy­phenyl)imino­methyl]naphthalen‐2(1H)‐onato‐κ3O,N,O′}zinc(II) ethanol solvate

In the crystal structure of the title compound, [Zn(C₁₈H₁₄NO₂)₂]·C₂H₆O, the Zn atom displays a highly distorted octa­hedral coordination involving the O and N atoms of two mol­ecules of the Schiff base 1‐[N‐(2‐methoxy­phenyl)imino­methyl]naphthalen‐2(1H)‐one, which acts as an O,N,O′‐tridentate ligand. The ethanol mol­ecule is bound to the methoxy group of one ligand mol­ecule via a hydrogen bond.     

7,8‐Dihydr­oxy‐4‐propyl‐1,2,3,4,4a,5,6,10b‐octa­hydro­benzo[f]quinolinium bromide monohydrate,a dopamine agonist

In the crystal structure of the title dopamine­rgic compound, C₁₆H₂₄NO₂⁺·Br⁻·H₂O, protonation occurs at the piperidine N atom. The piperidine ring adopts a chair conformation and the cyclo­hexene ring adopts a half‐chair conformation; together with the planar benzene ring, this results in a relatively planar shape for the whole mol­ecule. Classical hydrogen bonds (N—H⋯Br, O—H⋯Br and O—H⋯O) produce an infinite three‐dimensional network. Hydrogen bonds between water ­mol­ecules and Br⁻ anions create centrosymmetric rings throughout the crystal structure. Structural comparison of the mol­ecule with the ergoline dopamine agonist pergolide shows that it is the hydrogen‐bond‐forming hydr­oxy or imino group that is necessary for dopamine­rgic activity, rather than the presence of a phenyl or a pyrrole ring per se.     

4‐[(2‐Chloro­phenyl)­diazenyl]‐6‐methoxy‐2‐{[tris­(hydroxy­methyl)­methyl]­amino­methyl­ene}cyclo­hexa‐3,5‐dien‐1(2H)‐one

The structure of the title compound, C₁₈H₂₀ClN₃O₅, displays the characteristic features of azo­benzene derivatives. Intramolecular N—H⋯O, weak intramolecular C—H⋯O, and intermolecular O—H⋯O and C—H⋯O interactions influence the conformation of the mol­ecules and the crystal packing. Intermolecular hydrogen bonds link the mol­ecules into infinite chains, and the title compound adopts the keto–amine tautomeric form. The azo­benzene moiety of the mol­ecule has a trans configuration. The mol­ecule is not planar, and the dihedral angle between the two phenyl rings is 35.6 (2)°.     

(3R,4aS,5R)‐3‐Hydro­xy‐5‐isopropenyl‐3,8‐di­methyl‐4,4a,5,6‐tetra­hydro‐2(3H)‐naphthalenone

In the crystal structure of C₁₅H₂₀O₂, mol­ecules are associated by intermolecular hydrogen bonds between the hydroxy function and a keto group [O?O 2.770 (2) Å], forming chains along the [100] direction in the crystal. Both six‐membered rings in the decalin unit adopt envelope conformations; one section of the mol­ecule, encompassing the extended conjugation of a C=C double bond with an enone functionality [C=C—C=O = 175.6 (2)° and C=C—C=C = 176.6 (2)°], is flat, whilst the rest of the mol­ecule is folded relative to the constrained part. The stereochemistry was determined from the R‐(–)‐carvone starting material.     

Methyl 1‐(4‐chloro­benzyl)‐2‐(4‐methyl­piperazin‐1‐yl)‐1H‐benz­imidazole‐5‐carboxyl­ate hemihydrate

The title compound, C₂₁H₂₃ClN₄O₂·0.5H₂O, contains two independent mol­ecules in the asymmetric unit. In each mol­ecule the piperazine ring adopts a chair conformation; the deviations of the piperazine N atoms from the best plane through the remaining four C atoms are ?0.678 (3) and 0.662 (3) Å in mol­ecule A, and 0.687 (3) and ?0.700 (3) Å in mol­ecule B. The mol­ecules are linked by two hydrogen bonds of the O—H?N type involving the O atom of the water mol­ecule of crystallization.     

Bis(μ6‐cis‐2,4,6,8,10,12,14,16‐octa­methyl­cyclo­octa­siloxane‐2,4,6,8,10,12,14,16‐octolato)octa­kis[(dimethyl­formamide)copper(II)] dimethyl­formamide solvate enclosing a pyrazine mol­ecule

The title compound, [Cu₈(C₈H₂₄O₂Si)₂(C₃H₇NO)₈]·C₄H₄N₂·C₃H₇NO, features a sandwich‐like cage enclosing a pyrazine mol­ecule, both situated on a centre of inversion. In addition, the crystal structure contains one dimethyl­formamide mol­ecule which is disordered over a centre of inversion. The copper layer, containing eight atoms, is located between two siloxanolate fragments. The whole structure of Cu atoms and siloxanolate rings is distorted by the pyrazine mol­ecule, leading to an oval form. As a result, the angles between the Cu atoms differ at the copper layer. The difference in the angles could lead to some deviations in the Cu–Cu exchange inter­actions within the copper ring, which is of inter­est for mol­ecular magnetism.     

The antiestrogen [2‐(4‐benzyl­phenoxy)­ethyl]­diethyl­ammonium chloride

The crystal structure of the title compound, C₁₉H₂₆NO⁺·Cl^? (common name: N,N‐diethyl‐2‐[(4‐phenyl­methyl)phenoxy]‐ethan­amine hydro­chloride), contains one mol­ecule in the asymmetric unit. The planes through the two phenyl rings are roughly perpendicular. Protonation occurs at the N atom, to which the Cl^? ion is linked via an N—H?Cl hydrogen bond. The mol­ecule adopts an eclipsed rather than extended conformation.     

1‐Methyl‐5,6‐di­phenyl­pyrazine‐2(1H)‐thione

The title compound, C₁₇H₁₄N₂S, crystallizes in a triclinic unit cell, with two crystallographically independent mol­ecules in the asymmetric unit. The two independent mol­ecules pack in the same sense and form segregated layers along the c axis. The crystal is light‐stable and no dimers are formed under irradiation. The intermolecular distances between the potential reactive centers (the C‐3 and C‐5 ring positions) are 4.093 (4) and 5.643 (4) Å for mol­ecule A, and 4.081 (4) and 5.614 (4) Å for mol­ecule B.     

3‐(1‐Pyridinio)propane­sulfonate and 3‐(benzyl­dimethyl­ammonio)propane­sulfonate monohydrate

3‐(1‐Pyridinio)propane­sulfonate, C₈H₁₁NO₃S, and 3‐(benzyl­dimethyl­ammonio)propane­sulfonate monohydrate, C₁₂H₁₉NO₃S·H₂O, used as additives during protein refolding and crystallization, both crystallize in the monoclinic system in the P2₁/c space group, with one mol­ecule (or one set of mol­ecules) per asymmetric unit. The solvent water mol­ecule present in the second crystal structure results in the formation of a dimer through hydrogen bonds. The conformation of the propane­sulfonate moiety is similar in both structures.     

Gallic acid monohydrate

In the crystal structure of the title compound, 3,4,5‐tri­hydroxy­benzoic acid monohydrate, C₇H₆O₅·H₂O, the gallic acid mol­ecule has an intramolecular hydrogen bond involving a pair of hydroxyl groups, and it is also linked to a water mol­ecule by a three‐centre (bifurcated) OW—H?O hydrogen bond. The packing of the mol­ecules is stabilized by intermolecular O—H?O and C—H?O hydrogen bonds.     

Absolute configuration of (+)‐(S)‐2‐(5‐fluoro‐2‐methoxy‐1,4‐benzodioxan‐2‐yl)­imidazolinium bromide

The title compound, C₁₂H₁₄FN₂O₃⁺·Br^?, crystallizes in the non‐centrosymmetric P2₁2₁2₁ space group. The absolute configuration of the pharmacologically active mol­ecule could be resolved in the hydro­bromide salt, the structure of which is reported. The mol­ecule of the title compound has the S configuration. The molecular packing in the crystal is stabilized by weak N—H?Br [N?Br = 3.240 (4) and 3.302 (4) Å] hydrogen bonding.     

Di­methyl (1‐methyl‐1,3‐benzimidazol‐5‐yl)­amino­methyl­ene­propane­dioate monohydrate

In the title compound, C₁₄H₁₅N₃O₄·H₂O, there is a strong conjugation push–pull effect across the central double bond, as reflected in the molecular dimensions and the planarity of the en­amino­ne portion of the mol­ecule. The mol­ecule has an intramolecular hydrogen bond between the NH and CO groups in the Z configuration, adopting the chelated form. The two π systems of the mol­ecule (1‐methyl­benz­imidazole and en­amino­ne) are deconjugated and tilted with respect to each other by 15.6 (2)°. The solvent water mol­ecule is hydrogen bonded to the N¹ atom of the 1‐methyl­benzimidazolyl group.     

Alaninyl­tryptophan hydrate,glycyl­tryptophan dihydrate and tryptophyl­glycine hydrate

The crystal structures of the title tryptophan‐containing dipeptides, C₁₄H₁₇N₃O₃·H₂O, (I), C₁₃H₁₅N₃O₃·2H₂O, (II), and C₁₃H₁₅N₃O₃·H₂O, (III), respectively, contain at least one water mol­ecule of solvation. As a result, the crystal packing of these compounds is composed of regions of water‐mediated hydrogen bonding and tryptophan ring‐to‐ring stacking separated by the length of the mol­ecule. The tryptophan rings stack in a continuous layer that, when viewed edge‐on from the outermost part of the tryptophan ring, exhibits a herring‐bone motif. However, owing to the lack of direct overlap of adjacent rings, no degree of π contact or long‐range delocalization of ring systems is possible here. The overall molecular conformations of (I) and (III) contain a folding of one peptide over the other, such that a minimum in molecular volume occurs without any intramolecular hydrogen bonding. In these two dipeptides, extensive hydrogen bonding is observed to and from the single water mol­ecule of solvation. In the crystal structure of (II), however, an extended mol­ecule conformation complements a more extensive hydrogen‐bonding scheme involving two water mol­ecules of solvation per dipeptide.     

Mono­alkyl­ated 4′‐aryl‐substituted terpyridines

1‐Methyl‐2‐[4‐phenyl‐6‐(pyridinium‐2‐yl)­pyridin‐2‐yl]­pyridinium diperchlorate, C₂₂H₁₉N₃²⁺·2ClO₄⁻, (I), and 2‐[4‐(methoxy­phenyl)‐2,2′‐bipyridin‐6‐yl]‐1‐methyl­pyridinium iodide, C₂₃H₂₀N₃O⁺·I⁻, (II), both crystallize in the monoclinic space group P2₁/c. In contrast with the monocharged mol­ecule of (II), the doubly charged mol­ecule of (I) contains an additional protonated pyridine ring. One of the two perchlorate counter‐anions of (I) interacts with the cation of (I) via an N—H⋯O hydrogen bond. In (II), two mol­ecules related by a centre of symmetry are connected by weak π–π interactions, forming dimers in the crystal structure.